期刊文献+

血清IL-6、PCT、TNF-α与GBS感染孕妇不良妊娠结局的关系 被引量:1

Relationship between serum IL-6,PCT,TNF-αand adverse pregnancy outcomes in pregnant women with GBS infection
下载PDF
导出
摘要 目的分析血清白介素-6(IL-6)、降钙素原(PCT)、肿瘤坏死因子-α(TNF-α)与B族链球菌(GBS)感染孕妇不良妊娠结局的关系。方法选取2020年5月至2022年3月于首都医科大学附属北京天坛医院进行产检以及生产的125例GBS感染孕妇为研究对象(GBS组),另选取同期收治的健康产妇100名为对照组。对比GBS组、对照组血清IL-6、PCT、TNF-α水平;比较两组妊娠结局;分析影响GBS感染孕妇不良妊娠结局的单因素;采用多元Logistic回归分析影响GBS感染孕妇不良妊娠结局的危险因素。结果对照组IL-6、PCT、TNF-α水平均低于GBS组,差异有统计学意义(P<0.05);对照组早产、胎膜早破、胎儿窘迫、新生儿GBS感染以及新生儿病理性黄疸的发生率均低于GBS组,差异有统计学意义(P<0.05);经检查、追踪发现,GBS组有37例产妇有不良妊娠结局,88例产妇为正常妊娠结局;不良妊娠结局组与正常妊娠结局组孕周、是否为初产妇等指标比较,差异无统计学意义(P>0.05);两组年龄、GBS感染分级、血清IL-6、PCT、TNF-α水平比较,差异有统计学意义(P<0.05);经多元Logistic回归分析显示:年龄≥35岁、GBS感染分级为GBS带菌或GBS性绒毛膜羊膜炎、IL-6>0.463 ng/L、PCT≥0.5 ng/mL、TNF-α≥30 fmol/mL均是影响GBS感染孕妇不良妊娠结局的危险因素(P<0.05)。结论血清IL-6、PCT、TNF-α水平在GBS感染产妇不良妊娠结局患者中呈升高状态,三指标可作为监测、预防GBS感染产妇不良妊娠结局的重要指标。 Objective To analyze the relationship between serum interleukin-6(IL-6),procalcitonin(PCT),tumor necrosis factor-α(TNF-α)and adverse pregnancy outcomes in pregnant women infected with Group B streptococcus(GBS).Methods 125 GBS infection-positive women who underwent Beijing Tiantan Hospital,Capital Medical University and gave birth in this court from May 2020 to March 2022 were selected as the research subjects(GBS group),another 100 healthy pregnant women admitted during the same period were selected as the control group.The serum IL-6,PCT,and TNF-αlevels between the GBS group and the control group were compared.The pregnancy outcomes between the two groups were compared.The single factors that affected adverse pregnancy outcomes in pregnant women with GBS infection were analyzed.The multiple logistic regression was used to analyze the risk of adverse pregnancy outcomes in pregnant women with GBS infection factor.Results The levels of IL-6,PCT,and TNF-αin the control group were lower than those in the GBS group(P<0.05).The incidence rates of premature birth,premature rupture of membranes,fetal distress,neonatal GBS infection and neonatal pathological jaundice in the control group were low-er than those in the GBS group(P<0.05).After inspection and follow-up,it was found that 37 women in the GBS group had adverse pregnancy outcomes and 88 women had normal pregnancy outcomes;there was no statistically significant difference in the adverse pregnancy outcome group and the normal pregnancy outcome group in terms of gestational age,whether they were primipara,etc.(P>0.05).Comparing the age,GBS infection grade,serum IL-6,PCT,and TNF-αlevels between the two groups showed statistically significant differences(P<0.05).Multiple logistic regression analysis showed that:age≥35 years old,the classification of GBS infection as GBS carrier or GBS chorioamnionitis,IL-6>0.463 ng/L,PCT≥0.5 ng/mL,and TNF-α≥30 fmol/mL were risk factors for adverse pregnancy outcomes in pregnant women with GBS infection(P<0.05).Conclusion Serum IL-6,PCT,and TNF-αlevels are elevated in patients with adverse pregnancy outcomes in GBS-infected mothers.The three indicators can be used as important indicators for monitoring and preventing adverse pregnancy outcomes in GBS-infected mothers.
作者 杜雪冰 钱芳 王毅娟 魏静 DU Xuebing;QIAN Fang;WANG Yijuan;WEI Jing(Department of Medical Record,Beijing Tiantan Hospital Affiliated to Capital Medical University,Beijing,China,100160;Department of Laboratory Medicine,Beijing Tiantan Hospital Affiliated to Capital Medical University,Beijing,China,100160;Department of Obstetrics,Beijing Tiantan Hospital Affiliated to Capital Medical University,Beijing,China,100160)
出处 《分子诊断与治疗杂志》 2024年第1期23-26,31,共5页 Journal of Molecular Diagnostics and Therapy
基金 北京市科技计划项目(Z202300002010015)。
关键词 IL-6 PCT TNF-Α GBS感染 孕妇 不良妊娠结局 IL-6 PCT TNF-α GBS infection Pregnant women Adverse pregnancy outcomes
  • 相关文献

参考文献13

二级参考文献132

  • 1周妍,周欣,陈世荣.妊娠晚期B族链球菌感染和治疗对妊娠结局的影响[J].南京医科大学学报(自然科学版),2020,40(10):1537-1540. 被引量:10
  • 2申阿东,张桂荣,王咏红,杨永弘.B组链球菌的耐药性及红霉素耐药基因检测研究[J].中华儿科杂志,2005,43(9):661-664. 被引量:15
  • 3史晓萍,宗阿南,陶钧,王禄增.《关于善待实验动物的指导性意见》的研究[J].中国医科大学学报,2007,36(4):493-493. 被引量:73
  • 4Schrag S. Gorwitz R. Fultz-Butts K. et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep.2010;5ICRR-11): 1-22.
  • 5Castor ML, Whitney CG. Corno-Sabetti K. et al . Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol.2008;2008:727505. doi , 10.1155/ 2008/727505.
  • 6Valkenburg-van den Berg AW. Houtman-Roelofsen RI. Oostvogel PM. et al . Timing of group B streptococcus screening in pregnancy: a systematic review. Gynecol Obstet Invest. 2010; 69( 3) : 174-183.
  • 7Phares CR. Lynfield R. Farley MM. et al . Epidemiology of invasive group B streptococcal disease in the United States. 1999-2005. J AMA. 2008; 299 (17) : 2056-2065.
  • 8RANZCOG. Maternal Group B Streptococcus in Pregnancy: screening and management. RANZCOG statement C-Obs 19. Melbourne: Royal Australian and New Zealand College of Obstetricians and Gynaecologists. 2012: 1-19.
  • 9Leclercq R. Mechanisms of resistance to macrolides and lincosarnides , nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002; 34( 4) : 482-492.
  • 10Suzanne MG. Erin Cv Lisa M.etal. Antimicrobial resistance in group B streptococcus: the Australian experience. J Med Microbiol.2011;60(Pt 2) :230-235.

共引文献114

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部